skip to main content
Ngôn ngữ:
Giới hạn tìm kiếm: Giới hạn tìm kiếm: Dạng tài nguyên Hiển thị kết quả với: Hiển thị kết quả với: Dạng tìm kiếm Chỉ mục

Fluvastatin mitigates SARS-CoV-2 infection in human lung cells

iScience, 2021-12, Vol.24 (12), p.103469-103469, Article 103469 [Tạp chí có phản biện]

2021 The Author(s) ;2021 The Author(s). ;2021 The Author(s) 2021 ;ISSN: 2589-0042 ;EISSN: 2589-0042 ;DOI: 10.1016/j.isci.2021.103469 ;PMID: 34812415

Tài liệu số/Tài liệu điện tử

Trích dẫn Trích dẫn bởi
  • Nhan đề:
    Fluvastatin mitigates SARS-CoV-2 infection in human lung cells
  • Tác giả: Zapatero-Belinchón, Francisco J. ; Moeller, Rebecca ; Lasswitz, Lisa ; van Ham, Marco ; Becker, Miriam ; Brogden, Graham ; Rosendal, Ebba ; Bi, Wenjie ; Carriquí-Madroñal, Belén ; Islam, Koushikul ; Lenman, Annasara ; Gunesch, Antonia P. ; Kirui, Jared ; Pietschmann, Thomas ; Överby, Anna K. ; Jänsch, Lothar ; Gerold, Gisa
  • Chủ đề: Drugs ; Virology
  • Là 1 phần của: iScience, 2021-12, Vol.24 (12), p.103469-103469, Article 103469
  • Mô tả: Clinical data of patients suffering from COVID-19 indicates that statin therapy, used to treat hypercholesterolemia, is associated with a better disease outcome. Whether statins directly affect virus replication or influence the clinical outcome through modulation of immune responses is unknown. We therefore investigated the effect of statins on SARS-CoV-2 infection in human lung cells and found that only fluvastatin inhibited low and high pathogenic coronaviruses in vitro and ex vivo in a dose-dependent manner. Quantitative proteomics revealed that fluvastatin and other tested statins modulated the cholesterol synthesis pathway without altering innate antiviral immune responses in infected lung epithelial cells. However, fluvastatin treatment specifically downregulated proteins that modulate protein translation and viral replication. Collectively, these results support the notion that statin therapy poses no additional risk to individuals exposed to SARS-CoV-2 and that fluvastatin has a moderate beneficial effect on SARS-CoV-2 infection of human lung cells. [Display omitted] •Fluvastatin inhibits low (HCoV-229E) and high (SARS-CoV-2) pathogenic coronaviruses•SARS-CoV-2 infection does not affect statin-induced cholesterol biosynthesis arrest•Statin treatment does not alter SARS-CoV-2 innate immune responses in vitro•Fluvastatin downregulates protein translation and viral replication pathways Drugs; Virology
  • Nơi xuất bản: United States: Elsevier Inc
  • Ngôn ngữ: English
  • Số nhận dạng: ISSN: 2589-0042
    EISSN: 2589-0042
    DOI: 10.1016/j.isci.2021.103469
    PMID: 34812415
  • Nguồn: TestCollectionTL3OpenAccess
    PubMed Central
    SWEPUB Freely available online
Trở lại danh sách kết quả
Về trang trướcTrước Kết quả  10 Tiếp theoTới trang tiếp theo
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Đang tìm Cơ sở dữ liệu bên ngoài...